Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru YC W23 AI UPSC exam coaching for 60K+ students in India's most competitive civil services exam; $2.53M YC/FundersClub/GoodWater seed May 2024 with personalized AI mentor competing with Unacademy and PW for UPSC preparation.
SuperKalam is a Bengaluru, India-based AI-powered test preparation platform — backed by Y Combinator (W23) with $2.53 million in total funding including a $2 million seed in May 2024 led by Y Combinator and FundersClub with participation from Puneet Kumar, GoodWater Capital, Nurture Ventures, SuperCapital, and Pareto Ventures — providing 60,000+ Indian students with AI-powered mentorship and personalized study guidance for the UPSC Civil Services Examination, India's most competitive government job exam that receives 500,000-900,000 applications annually for approximately 1,000 positions. Founded in 2023 by Vimal Singh Rathore and Aseem Gupta (IIT Madras alumni), SuperKalam targets the UPSC aspirant market where preparation typically requires 1-3 years of intensive study and coaching costs ₹50,000-₹200,000 per year.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.